Cresco Labs Announces Conference Participation for December 2022

CHICAGO--(BUSINESS WIRE)-- Cresco Labs (CSE: CL) (OTCQX: CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today announced its executive team will participate in the following conferences this month:

Cowen Cannabis Conference, December 6-8, 2022 (Virtual): Chief Executive Officer Charles Bachtell will participate in a fireside chat moderated by Vivien Azer, Managing Director, on December 6 at 11:35 am EST. Management will participate in one-on-one meetings on December 6.

Stifel Future of Health Conference, December 7, 2022 (Virtual): Chief Executive Officer Charles Bachtell will participate in an MSO panel moderated by analyst Andrew Partheniou from 12:00 -12:55 pm EST, and management will participate in one-on-one meetings.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221205005257/en/

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
[email protected]

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
[email protected]

For general Cresco Labs inquiries:
312-929-0993
[email protected]

Source: Cresco Labs

You May Also Be Interested In

• Nubank Strengthens Its Brazil Operation With a New Banking License
• Lathrop GPM Combines with HG Law Expanding Global IP Capabilities, Adding Offices in New York and London and Continued Growth in Silicon Valley
• SmartFinancial Announces Results for the Second Quarter 2026, Regular Quarterly Cash Dividend